ABSTRACT
INTRODUCTION
The murine respiratory system is commonly used for disease modelling as well as for testing and developing potential treatments for respiratory diseases such as cystic fibrosis (CF), a genetic condition that primarily affects the conducting airways of the lung. Our group routinely uses the nose and lungs of normal and CFTR null mice as in vivo test sites for developing a gene therapy treatment for CF airway disease 1, 2 . CFTR null mice do not exhibit CF pathophysiology in the lungs 3 , so in these mice the target of our gene therapy treatment is the ciliated respiratory epithelium in the proximal nose. Our HIV-1 based lentiviral (LV) gene vector used to package the therapeutic (CFTR) gene and / or a reporter gene is delivered to the nose or trachea by in vivo bolus instillation, primarily because this method produces better transduction than currently available aerosolisation methods.
The success of airway gene transfer protocols depends on reliable fluid dosing but despite using standardized delivery techniques we, along with other groups, report large variability in both electrophysiological gene transfer measurements and reporter gene histological assessments [2] [3] [4] .
Heterogeneous dose distributions that may occur in the physically complex nose and trachea could be one cause of this variability.
All standard imaging modalities (i.e. radiographs and ultrasound) poorly discriminate soft tissues from air-containing structures and cannot be used to visualize fluid dosing dynamics in the mouse nose and lung due to their limited spatial and temporal resolution. Similarly, while capable of providing 3-dimensional (3D) information via tomographic approaches, small-animal µ-CT and µ-MRI cannot be used to track high speed dynamic events such as fluid dosing at high spatial resolutions. The ultimate location of trans-nasally delivered solutions has been determined in 3D using PET 5 , but the acquisition speed and spatial resolution of nuclear medicine, SPECT and PET are too low to permit imaging of the dynamics of the fluid delivery.
Synchrotron phase contrast X-ray imaging (PCXI) 6, 7 can be used to monitor the fate of a fluid dose bolus with high temporal and spatial resolution in the period immediately after delivery. A synchrotron is a large machine that accelerates electrons to close to the speed of light. As the electrons are deflected through a magnetic field (e.g. at a bending magnet) they create extremely bright and coherent synchrotron light that is directed into experimental hutches. PCXI provides enhanced image contrast by utilizing X-ray refraction in addition to conventional X-ray absorption and is capable of producing soft tissue contrast even where the absorption differences are small, particularly in the lungs (see figure 1 on Page 5033 in Lewis et. al. 8 for a comparison between PCXI and standard absorption contrast). Propagation-based PCXI requires a spatially coherent Xray source, a property that is readily achievable using a synchrotron. The boundaries between tissue and air are enhanced by the phase changes in the incident X-ray wave induced by their differences in X-ray refractive index 6, 7 . We have described the advantages of PCXI for airway surface imaging in small animals 9, 10 ; for monitoring the post-deposition behaviour of particulates on live mouse nasal and tracheal airways 11, 12 ; and for non-invasively tracking how a fluid bolustypical of that used in airway gene therapy dosing -moves through the airways of live and intact small animals 13 .
Our previous fluid dosing study 13 showed the immediate fate of fluids instilled into the nose and trachea of live anaesthetized mice, demonstrating that the overall distribution of the dose, the effectiveness of the delivery method and the persistence of the delivered dose can now be visualized. The limitations of that study included a small sample size, small delivered fluid volumes, and significant motion artefacts from animal movement during the lung studies. Importantly, the temporal resolution (1 Hz for nasal studies and 1.33 Hz for lung studies) was too low to accurately track the rapid fluid movement. The aim of the present study was to utilise improved image capture techniques to permit more accurate monitoring of fluid dosing dynamics in the nose and lungs of live mice using two dimensional PCXI. Specifically, we substantially increased the imaging frame rate, included larger fluid doses and utilized a paralytic agent during the lung imaging studies to minimize unwanted body movements.
METHODS
Experiments were performed on the BL20B2 bending magnet beamline at the SPring-8 synchrotron radiation facility in Japan. All experiments were approved by the Animal Ethics
Committee of SPring-8, and of the Women's and Children's Health Network (Adelaide). Mice were anaesthetized using 80 mg/kg i.p. pentobarbital (Somnopentil, Pitman-Moore, Washington
Crossing, USA), with an additional 30 mg/kg i.p top-up 10 minutes later, just prior to imaging. Body temperature was maintained using an infrared heat lamp and monitored with a rectal thermometer.
Mice were typically anaesthetized for a maximum of 30 minutes and were humanely killed via overdose of pentobarbital after completion of each experiment.
Imaging setup
The imaging hutch was located in the SPring-8 Biomedical Imaging Centre, 211 meters from the source 14 , and the imaging layout was as described previously 9, 13 (see Figure 1 ). Monochromatic 18 keV (λ=0.7Å) X-rays were selected using a Si(111) double-crystal monochromator to provide both maximum flux and iodine contrast 15 . A propagation (sample to detector) distance of 1.35 m was chosen to produce optimal phase contrast for airway imaging. X-rays were converted to visible light using a GADOX (P43, Gd 2 O 2 S:Tb) scintillator coupled to an 85 mm lens (BM5, Hamamatsu Photonics) and images were captured using an EMCCD detector (C9100-02, Hamamatsu Photonics) and a 200 mm camera lens. The CCD detector had an array size of 1000 x 1000 pixels and an 8 µm native pixel size. This setup resulted in an effective isotropic pixel size of 18.8 µm and a field of view of 18.8 mm x 18.8 mm. An exposure length of 100 ms was chosen to capture sufficient photons to fill the potential dynamic range (2 14 grey levels) of the detector, provide the maximal signal to noise ratio without detector saturation, and minimize blurring from animal movement.
Nasal studies
Animals were prepared as previously described 13 . Briefly, 15 anaesthetized female C57/Bl6 mice (~20 grams) were individually secured head-high to a polyethylene imaging board 16 with their incisors hooked over a wire loop and their limbs, shoulders and torso taped to the board to minimize body movements. The imaging area (head) was brushed with a thin layer of glycerol to eliminate air in the fur layer and minimize fur interference in the PCXI images. The imaging board was connected to the hutch sample stage such that the mouse was held head-high and the X-ray beam passed dorso-ventrally through the nose. A PE10 polyethylene cannula (SteriHealth, Melbourne, Australia) was positioned using a micromanipulator so its tip was 1-2mm above the right nostril, to simulate our normal (hand-delivered) nasal gene vector delivery setup ) and water (to produce an isotonic solution) was used as the surrogate fluid for both LPC and the LV vector. In three mice we tested the use of saline only as the surrogate fluid to demonstrate the effectiveness of using iomeprol for visualizing the fluid location. To ensure accurate dose initiation and delivery the syringe and PE tubing were primed and tested prior to each experiment.
Images were captured at 6.67 Hz. After 15 seconds (100 frames) of baseline image collection, the contrast mix was delivered in a single bolus at a constant rate of 0.4 µl/sec; thus the 4 µl dose was delivered in 10 sec, the 10 µl dose in 25 sec and the 20 µl dose in 50 sec. Mice "sniffed" the fluid into one nostril by their normal tidal volume inhalations. The cannula tip did not make contact with the mouse nose at any time. Image capture continued for five minutes, creating a dataset consisting of a total of 2100 images per mouse.
Lung studies
A similar protocol was used for the lung imaging. Ten mice were anaesthetized, then intubated with a 20Ga i.v. catheter (Insyte, Becton Dickinson, Utah, USA) 16 . This endotracheal (ET) tube was inserted into the trachea to a depth of 22.5 mm from the nose tip, chosen to place the ET tube tip below the fifth cartilage ring (approximately half way between the epiglottis and the carina, based on measurements made in dissected animals prior to the imaging studies). The catheter Luer hub was immediately cut off to enable the ET tube to be directly connected to the ventilator circuit and ensure respiratory dead-space was minimized. The imaging area (chest and back) was brushed with a thin layer of glycerol to improve image quality. Mice were ventilated at 80 breaths/min with a tidal volume of 30 ml/kg (no pressure limit) and ~3 cmH 2 O of PEEP using a flexiVent small animal ventilator (Scireq, Canada). The ventilatory profile was configured with a forced inspiration of 350 msec and a passive expiration of 400 msec. After connection to the ventilator mice were paralysed using pancuronium (Mioblock, 0.5 mg/kg i.p.) to minimize unwanted respiratory and skeletal muscle movements. Fluid doses were delivered via a heat-thinned PE10 polyethylene cannula placed inside the ET tube via an airtight slit in the silicone ventilator tubing and advanced so that its tip extended 5mm below the end of the ET tube 13, 16 , a similar depth to that used in our mouse lung gene transfer studies 1 . The syringe pump was used to remotely deliver the bolus of contrast mixture via this smaller cannula.
Our lung gene transfer studies use doses of 15 to 30 µl 1 , so these are the two doses we tested (n=5 each). Our previous fluid dosing study suggested that rapid dose deliveries better target the conducting airways and minimize dose losses via retrograde movement around the delivery and ET tubes 13 , so the maximum infusion rate of the syringe pump (~4.2 µl/min) was used for both volumes.
Starting at the beginning of each breath the ventilator triggered acquisition of five images at equally spaced intervals of 150 msec. This resulted in three frames during inspiration and two frames during the relatively motion-free period after passive-expiration. After 15 seconds of baseline collection (20 breaths, 100 images), a sample of the contrast mix was delivered. For the 15 µl and 30 µl volumes the fluid was delivered as a single bolus over 3.6 sec and 7.2 sec respectively (max infusion rate). Imaging continued for a further 5 minutes creating a dataset consisting of a total of 2100 images per mouse.
Post experimental analyses
Post processing was performed as previously described 13 . All images were flat-field and darkfield corrected and image subtraction algorithms were used to locate regional changes in image brightness (Matlab 2009b, The Mathworks, USA).
For the nasal studies each frame was subtracted from the best matched baseline imagedetermined by calculating the two-dimensional correlation coefficient between the current frame and each of the baseline frames -to locate regions where the image brightness had changed and so reveal fluid motion (i.e. background subtraction of the mouse anatomy). A constant threshold of 128 grey values (1/32 the dynamic range) was used to select only the large intensity changes and a 3x3 median-filter was applied to reduce noise. The presence and / or motion of the delivered fluid was highlighted by pseudo-colouring the original images. The regions where the image became darker (more contrast fluid) were coloured with a red to yellow colour scale, and those that became lighter were coloured with a blue to purple colour scale (see Figure 2 ). The volume of contrast fluid (i.e. the amount of artificial colour) present in the nose in each image frame was also determined semi-quantitatively by summing the pixels in a central vertical region of interest of dimensions 300 x 1000 pixels from the background subtracted images. This value was calculated for each image collected from every mouse and presented as an average over time for each fluid volume.
The lung studies were processed differently. For these images the brightness difference between successive breaths (i.e. frame differencing) was calculated by subtracting each frame from the corresponding frame in the previous breath. This technique was used to compensate for the greater confounding movements produced by the continuous respiratory and cardiac motion. Each frame was converted to an RGB image and the red, green and blue channels were adjusted to show the regions where the brightness decreased (i.e. presence of contrast fluid) in green pseudocolor. This visualization method minimized the effects of body motion and eliminated the need to choose a different threshold for each animal that would complicate between-animal comparisons.
For high quality motion-detection the background must remain still compared to the foreground objects (i.e. the contrast fluid) to be detected, so we made special efforts to minimize the movement of the mouse during imaging, hence the use of restraining boards, respiratory-gating and respiratory muscle paralysis as described above.
The amount of contrast fluid that entered the left and right lungs was calculated in a similar manner to the nasal study. Each image was divided into left and right halves using a vertical line that passed through the carina. The proportion of contrast fluid entering each lung was determined by calculating the sum of the pixels in the frame-difference images. Only frames 100 to 250 were analysed (i.e. the fluid dosing period) to minimise the contributions of extraneous body movements.
RESULTS
The small volumes of the 1:1 mixture of water and contrast fluid were well-tolerated by the anaesthetized mice. All mice survived to the end of the imaging sequences. Occasional respiratory perturbations occurred with the large volume deliveries, but subjectively these appeared to occur at a similar incidence to that experienced during our gene transfer studies.
Nasal dose delivery
Soon after delivery initiation (see 
Lung dose delivery
In this study the progress of delivered fluid into the lung was monitored by the change in X-ray contrast between breaths and was represented by green artificial colouring in the airways (see lungs (see Figure 5 ). In all but one animal, distribution was equally split between the two sides.
Together these findings demonstrate that the distribution of fluid doses was not-uniform, both intransit or when measured as a final distribution. In some cases the fluid boli did not span the full width of the airways, appearing 'drop-like' on the airway wall. Nevertheless these partial boli moved progressively toward the periphery in concert with ventilatory flows. Depending on the anatomical orientation of the particular distal airway region, the fluid movement into that region could appear in a "starburst" pattern, clearly revealing the simultaneous distribution into several airway branches at once (see Figure 6 and Supplementary Movie 3). It was rare for substantial retrograde movement of the fluid dose to occur after it entered the mainstem bronchi.
In some animals (3 of 10 mice; 1 x 15 µl and 2 x 30 µl) fluid instillation resulted in a respiratory pause despite the ventilator continuing to operate, increasing the effective delivery time into the lung. In all cases some of the fluid initially expelled from the delivery cannula back-filled between the ET tube and the inner tracheal walls and remained trapped there for the duration of the imaging.
This fluid oscillated in the trachea around the ET tube with oscillations from the ventilator, and during respiratory pauses the oscillation was often apparent just distal to the ET tube. The oscillating fluid was often not artificially coloured (appearing dark grey) because there was little fluid progression between breaths (and thus it was not coloured green by the analysis algorithm).
Despite the pause, the dose fluid slowly progressed down the trachea and normal ventilation appeared to resume when the oscillating fluid front reached the carina. Figure 7 shows the ventilator airway pressure spanning one of these events; airway pressure increased substantially and was sustained at a higher level during the pause, reducing immediately to slightly above the baseline pressure when normal ventilation resumed. In all animals a peak in airway pressure observed at delivery of the dose was followed by a gradual reduction throughout the remainder of the study.
DISCUSSION
The primary goal of this study was to document and understand the dynamics of fluid bolus dose delivery into the nose and trachea of live mice using synchrotron PCXI in a manner that would improve understanding of airway gene transfer dosing in mice. To our knowledge these studies represent the first detailed analysis of real-time fluid dose delivery and distribution effects in the airways of intact mice, and we suggest these findings have wider application to the understanding of the variability and destinations of fluid doses delivered into mouse airways for many other types of respiratory research.
Our previous fluid dosing study 13 was limited by the slow image capture rate. In the nose the capture rate was insufficient for visualizing the rapid fluid movements -for example the filling of the nose (See Supplementary Movie 1) -that occurred upon dosing. In the lung the effectiveness of ventilation could not be visualized because only a single image was taken immediately prior to each ventilator-driven inspiration (i.e. at the end of each breath). The primary effect was that in the lung the delivery dynamics within each breath, and their implications on dose distribution, could not be appreciated. In particular, the cessation of breathing that occurred in this current study in some mice immediately after fluid delivery may have also occurred in the previous study, but could not have been detected with that slower capture rate. In addition, the precision with which fluid movement could be tracked was improved in this study through the use of a paralytic agent; this minimized the occurrence of confounding respiratory and skeletal muscle movements.
Nasal airways
Our findings provide information pertinent to mice oriented vertically for nasal fluid dose delivery, as is common in a range of research settings. We have shown that specific regions of the nasal airways can be targeted by altering the dose volume. Furthermore, it is unlikely that the lung will be dosed if volumes less than ~ 4 µl (in ~ 20 g mice) are used. These dosing differences will be of value in targeting only the olfactory region for drug treatment studies. While the use of larger volumes will access the nasopharyngeal airway, it is difficult to predict whether fluid movement would be localized to the wall on the treated side (Figure 2c ), or reach all of the nasopharynx via the reciprocating movement of the dose that often eventuates (e.g. as occurred after the frame shown in Figure 2c ; see Supplementary movie 1). The presence of reciprocating dose fluid after larger volumes also increases the likelihood of retrograde fluid delivery into the contralateral anterior nasal airways, and this effect may prevent use of the un-dosed nasal airway as a withinanimal control site. Alternatively, the reciprocating fluid will tend to coat the circumference of the nasal lumen which may be of benefit in circumstances where treatment of the entire nasopharynx lumen is desired.
As the contrast fluid entered the nasal airway the magnitude of the difference in pixel intensity from baseline increased in proportion to the amount of contrast agent present. Figure 3 showed that we could provide a degree of quantification of the dynamic movement of the fluid through the nasal airways. That analysis revealed the 'holding capacity' of the portion of the mouse nose shown in these images is between 4 and 10 µl (~7.5 µl based on Figure 3 ). The implication for our nasal airway gene transfer studies is that 4 µl pre-treatment doses will be limited to the anterior nose, while 20 µl gene vector doses will reach both the nose and more distal regions such as the lung or gut, as proposed in our previous study 13 .
Lung airways
Despite using identical dose delivery conditions for each mouse there was large variability in the manner in which the fluid distributed through the airways, as well as its ultimate destination in the lung. For most deliveries the fluid initially went to either the left or right bronchi, although in some (n=2) a simultaneous bilateral delivery occurred. In all cases the ET tube was set to a standard depth, well above the carina, however, the placement of the tip (i.e. orientation and angle) may have influenced this outcome. The preferential dosing of one side of the lung could be an effect of the ventilator and ET tube, or alternatively, it could be a normal physiological response to fluid dosing that has not previously been visualised. Importantly, this finding suggests that expectations of uniform dosing cannot be predicted from a bolus delivery into the upper trachea. Despite the Compared to PET, SPECT or planar gamma camera imaging, the spatial and temporal resolution of this PCXI technique are far superior, and these results could not have been obtained using any other technique. The high flux produced by the synchrotron (allowing high temporal resolution), combined with the ability to perform phase contrast imaging (resulting in excellent anatomical detail and fluid localisation) makes this technique unique in its ability to capture dynamic images of fluid dosing. We believe that this research tool has the ability to answer many questions related to fluid dosing, pulmonary drug delivery and hopefully in the future to aerosol delivery to the airways of various animal models. However, in its current form and at the resolution used it is unlikely to have application in humans, primarily due to the radiation level present (the amount of radiation delivered increases to the 4th power of the resolution 22 ). Nevertheless, some synchrotron facilities have begun to implement human clinical programs for other types of analyses including mammographic imaging 23 and synchrotron stereotactic radiation therapy for cancer treatment 24 .
The use of high-energy monochromatic synchrotron X-rays also enables phase effects to be detected without any absorption using a technique such as diffraction enhanced imaging 25 . This means it is theoretically possible to obtain X-ray phase images with zero absorbed dose. Clinical Xray systems that utilise this mechanism are currently under development. With continuing advances in technology human applications of synchrotron radiation are expected to evolve towards advanced, dose-acceptable imaging for use in the clinic.
This study has several limitations. The primary limitation is the requirement of using a synchrotron -of which there are approximately 40 worldwide -to gather these image sequences with high temporal and spatial resolution. The need to deliver ionising radiation also affects the type of studies that can be performed; low delivered radiation doses are essential if animals are allowed to recover after an imaging experiment. Nonetheless, we propose that these findings are unique and especially informative for respiratory researchers using mouse models. The requirement for a synchrotron also makes it logistically very difficult to perform this type of study using a reporter gene vector fluid dose (rather than a surrogate contrast fluid dose) which would allow the dose distribution to be correlated with resulting gene expression. The Biosafety level 2 conditions required for delivering our HIV-1 based lentiviral vector are difficult or impossible to achieve in a synchrotron imaging hutch.
The iodine-based contrast agent is not a normal dose agent for airways and may alter the physiological response; however, we demonstrated that saline alone cannot be detected with sufficient sensitivity to be of value in monitoring dose distributions after delivery. In this study we did not perform a detailed calibration to determine the relationship between X-ray absorption and the amount of contrast agent present in the airways. As a result we cannot precisely quantify the 
Figure 5 | Proportion of fluid delivered to each lung
The mouse lung anatomy was simplified and assumed to consist of only left and right lung lobes that were divided along a vertical line passing through the carina. The amount of fluid entering each lung was semi-quantatively calculated based on the sum of the pixels from the frame-difference images, and was not statistically significantly different (n.s. paired t-test, n=10). Only in one mouse did substantially more fluid enter the left lung than the right. 
